+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Dihydroberberine

BP0492
483-15-8
98%
Biopurify
Berberis thunbergii DC.
Dihydroberberine has anti-tumor activity. It also improves in vivo efficacy in terms of counteracting increased adiposity, tissue triglyceride accumulation, and insulin resistance in high-fat-fed rodents, thus is potential therapeutic reagents for type 2 diabetes treatment.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0492-20mg 20mg
BP0492-100mg 100mg
BP0492-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

TLR4 AMPK TNF PPARG PIK3CA NFKB1 IL6 IL1B MYD88 HSP90AA1
TLR4 AMPK TNF PPARG NFKB1 IL6 IL1B LDLR INSR MYD88
GYRA GYPB DHFR MECA PENA
BCL2 AMPK TNF PPARG PIK3CA EGFR NFKB1 KCNH2 IL6 PDGFR HSP90AA1

Dihydroberberine Related Products

Product drug property prediction parameters

  • 40.1600

  • 4.0430

  • 4.0422

  • .0043

  • 7.1495

  • 33.5703

  • High

  • 91.5576

  • 2.7327

  • No

  • Yes

  • Yes

  • No

  • Yes

  • No

  • 1.2

  • No

  • Yes

  • No

  • Yes